Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MERTK | Q12866 | 6/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.54 |
| ▸ | PDE5A | O76074 | 2/20 | 0.51 |
| ▸ | ACP1 | P24666 | 2/20 | 0.51 |
| ▸ | OGG1 | O15527 | 1/20 | 0.50 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.49 |
| ▸ | GBA1 | P04062 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CCR4 | P51679 | 1/20 | 0.46 |
| ▸ | WHR1 | P49842 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14256546 | 0.82 | MERTK (0.51) | MERTKNPY5RPDE5AACP1OGG1 | |
| SCHEMBL14256632 | 0.81 | MERTK (0.70) | MERTKNPY5RPDE5AACP1OGG1 | |
| SCHEMBL27224044 | 0.78 | MERTK (0.81) | MERTKNPY5RPDE5AACP1OGG1 | |
| SCHEMBL24649614 | 0.77 | NPY5R (0.79) | MERTKNPY5RPDE5AACP1OGG1 | |
| SCHEMBL14256542 | 0.77 | APP (0.60) | MERTKNPY5RPDE5AACP1OGG1 | |
| SCHEMBL14256554 | 0.77 | MERTK (0.61) | MERTKNPY5RPDE5AACP1OGG1 | |
| SCHEMBL14256539 | 0.75 | APP (0.57) | MERTKNPY5RPDE5AACP1OGG1 | |
| SCHEMBL8889634 | 0.73 | MERTK (0.98) | MERTKNPY5RPDE5AACP1OGG1 | |
| SCHEMBL24649758 | 0.73 | MERTK (0.98) | MERTKNPY5RPDE5AACP1OGG1 | |
| SCHEMBL30896250 | 0.73 | MERTK (0.98) | MERTKNPY5RPDE5AACP1OGG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080058312-A1 | Modulators of hepatocyte growth factor/c-Met activity | ANGION BIOMEDICA CORPORATION (US) | 2008-03-06 | — | — | US | disclosed |
| US-20080058312-A1 | Modulators of hepatocyte growth factor/c-Met activity | ANGION BIOMEDICA CORPORATION (US) | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080058312-A1 | Modulators of hepatocyte growth factor/c-Met activity | HGF, MET, HDGF | MERTK 58/4885NPY5R 3095/4885PDE5A 2957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.